| Stage | SPXC | % of rev | ULS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $715M | 100.00% | $816M | 100.00% | ULS ×1.14 |
| Gross profit | $280M | 39.12% | $417M | 51.10% | ULS +12.0pp |
| Operating income | $115M | 16.14% | $150M | 18.38% | ULS +2.2pp |
| Pre-tax income | $106M | 14.88% | $338M | 41.42% | ULS +26.5pp |
| Net income | $82M | 11.46% | $254M | 31.13% | ULS +19.7pp |
| Stage | SPXC | ULS | Gap · A − B |
|---|---|---|---|
| Revenue | $715M100.00% | $816M100.00% | ULS ×1.14 |
| Gross profit | 39.12%$280M | 51.10%$417M | ULS +12.0pp |
| Operating income | 16.14%$115M | 18.38%$150M | ULS +2.2pp |
| Pre-tax income | 14.88%$106M | 41.42%$338M | ULS +26.5pp |
| Net income |
| 11.46%$82M |
| 31.13%$254M |
| ULS +19.7pp |
No shared counterparties.